General Information of DTT (ID: TTA8PLI)

DTT Name Casein kinase I epsilon (CSNK1E) DTT Info
Gene Name CSNK1E

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Preclinical Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Umbralisib DMYRBO1 Follicular lymphoma 2A80 Approved [1]
------------------------------------------------------------------------------------
3 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
IC261 DMXB95R Pancreatic cancer 2C10 Preclinical [2]
PF-4800567 DM8P9ST Chronic lymphocytic leukaemia 2A82.0 Preclinical [3]
PF-670462 DMTJBP9 Chronic lymphocytic leukaemia 2A82.0 Preclinical [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2021
2 Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem. 2000 Jun 30;275(26):20052-60.
3 Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. J Pharmacol Exp Ther. 2009 Aug;330(2):430-9.
4 Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. Blood. 2018 Mar 15;131(11):1206-1218.